Risperidone and the 5-HT2A Receptor Antagonist M100907 Improve Probabilistic Reversal Learning in BTBR T+tf/J Mice

Autism Research

Volumn 7, Issue 5, 2014, Pages 555-567

  Amodeo, Dionisio A ^a   Jones, Joshua H ^a   Sweeney, John A ^b   Ragozzino, Michael E ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Autism; BTBR; Cognitive flexibility; Reversal learning; Risperidone; Serotonin

Indexed keywords

FLUOROBENZENE; NEUROLEPTIC AGENT; PIPERIDINE DERIVATIVE; RISPERIDONE; SEROTONIN 2 ANTAGONIST; SEROTONIN 2A RECEPTOR; VOLINANSERIN;

ANIMAL; AUTISM; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; INBRED MOUSE STRAIN; LEARNING; MALE; MOUSE;

ANIMALS; ANTIPSYCHOTIC AGENTS; AUTISTIC DISORDER; DISEASE MODELS, ANIMAL; FLUOROBENZENES; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; PIPERIDINES; PROBABILITY LEARNING; RECEPTOR, SEROTONIN, 5-HT2A; REVERSAL LEARNING; RISPERIDONE; SEROTONIN 5-HT2 RECEPTOR ANTAGONISTS;

EID: 84939260745     PISSN: 19393792     EISSN: 19393806     Source Type: Journal    
DOI: 10.1002/aur.1395     Document Type: Article

References (78)

1. Aguilar M.A., Rodriguez-Arias M., Marí-Sanmillán M.I., & Miñarro J. (1997). Effects of risperidone on conditioned avoidance responding in male mice. Behavioural Pharmacology, 8, 669-676.
2. Aman, M.G., De Smedt, G., Derivan, A., Lyons, B., & Findling, R.L. (2002). Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. The American Journal of Psychiatry, 159, 1337-1346.
3. Amodeo, D.A., Jones, J.H., Sweeney, J.A., & Ragozzino, M.E. (2012) .Differences in BTBR T+tf/J and C57BL/6J mice on probabilistic reversal learning and stereotyped behavior. Behavioural Brain Research, 227, 64-72.
4. Baker, P.M., Thompson, J.L., Sweeney, J.A., & Ragozzino, M.E. (2011). Differential effects of 5-HT(2A) and 5-HT(2C) receptor blockade on strategy-switching. Behavioural Brain Research, 219, 123-131.
5. Bishop S.L., Richler J., Cain A.C., & Lord C. (2007). Predictors of perceived negative impact in mothers of children with autism spectrum disorder. American Journal of Mental Retardation, 112, 450-461.
6. Bodfish, J.W., Symons, F.J., Parker, D.E., & Lewis, M.H. (2000). Varieties of repetitive behavior in autism: Comparisons to mental retardation. Journal of Autism and Developmental Disorders, 30, 237-243.
7. Brown, H.D., Amodeo, D.A., Sweeney, J.A., & Ragozzino, M.E. (2012). The selective serotonin reuptake inhibitor, escitalopram, enhances inhibition of prepotent responding and spatial reversal learning. Journal of Psychopharmacology, 26, 1443-1455.
8. Canitano, R., & Scandurra, V. (2011). Psychopharmacology in autism: An update. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35, 18-28.
9. Chadman, K.K., (2011). Fluoxetine but not risperidone increases sociability in the BTBR mouse model of autism. Pharmacology, Biochemistry, and Behavior, 97, 586-594.
10. Cho, I.H., Yoo, H.J., Park, M., Lee, Y.S., & Kim, S.A. (2007). Family-based association study of 5-HTTLPR and the 5-HT2A receptor gene polymorphisms with autism spectrum disorder in Korean trios. Brain Research, 1139, 34-41.
11. Chudasama, Y., & Robbins, T.W. (2003). Dissociable contributions of the orbitofrontal and infralimbic cortex to Pavlovian autoshaping and discrimination reversal learning: Further evidence for the functional heterogeneity of the rodent frontal cortex. Journal of Neuroscience, 23, 8771-8780.
12. Cook E., & Leventhal B. (1996). The serotonin system in autism. Current Opinion in Pediatrics, 8, 348-354.
13. Coutinho A.M., Oliveira G., Morgadinho T., Fesel C., Macedo T.R., etal. (2004). Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism. Molecular Psychiatry, 9, 264-271.
14. D'Cruz, A.M., Ragozzino, M.E., Mosconi, M.W., Shrestha, S., Cook, E.H., & Sweeney, J.A. (2013). Reduced behavioral flexibility in autism spectrum disorders. Neuropsychology, 27, 152-160.
15. 2 receptors in reversal learning. Neuroscience, 162, 118-127.
16. Dias, R., Robbins, T.W., & Roberts, A.C. (1997). Dissociable forms of inhibitory control within prefrontal cortex with an analog of the Wisconsin Card Sort Test: Restriction to novel situations and independence from "on-line" processing. Journal of Neuroscience, 17, 9285-9297.
17. Dove, D., Warren, Z., McPheeters, M.L., Taylor, J.L., Sathe, N.A., & Veenstra-VanderWeele, J. (2012). Medications for adolescents and young adults with autism spectrum disorders: A systematic review. Pediatrics, 130, 717-726.
18. Findling, R.L., McNamara, N.O.R.A., Branicky, L.A., Schluchter, M.D., Lemon, E., & Blumer, J.L. (2000). A double-blind pilot study of risperidone in the treatment of conduct disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 509-516.
19. Floresco, S.B., Magyar, O., Ghods-Sharifi, S., Vexelman, C., & Tse, M.T. (2006). Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set shifting. Journal of Neuroscience, 31, 297-309.
20. Fombonne, E. (2009). Epidemiology of pervasive developmental disorders. Pediatric Research, 65, 591-598.
21. Furr, A., Lapiz-Bluhm, M.D., & Morilak, D.A. (2012). 5-HT2A receptors in the orbitofrontal cortex facilitate reversal learning and contribute to the beneficial cognitive effects of chronic citalopram treatment in rats. The International Journal of Neuropsychopharmacology, 15, 1295-1305.
22. Gabriele, S., Sacco, R., & Persico, A.M. (2014). Blood serotonin levels in autism spectrum disorder: A systematic review and meta-analysis. European Neuropsychopharmacology, 24, 919-929.
23. Geurts, H.M., Corbett, B., & Solomon, M. (2009). The paradox of cognitive flexibility in autism. Trends in Cognitive Sciences, 13, 74-82.
24. Goldman, S., Wang, C., Salgado, M.W., Greene, P.E., Kim, M., & Rapin, I. (2009). Motor stereotypies in children with autism and other developmental disorders. Developmental Medicine & Child Neurology, 51, 30-38.
25. Gould, G.G., Hensler, J.G., Burke, T.F., Benno, R.H., Onaivi, E.S., & Daws, L.C. (2011). Density and function of central serotonin (5-HT) transporters, 5-HT1A and 5-HT2A receptors, and effects of their targeting on BTBR T+tf/J mouse social behavior. Journal of Neurochemistry, 116, 291-303.
26. Hollander E., Phillips A., Chaplin W., Zagursky K., Novotny S., etal. (2005). Placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology, 30, 582-589.
27. Hollander E., Soorya L., Chaplin W., Anagnostou E., Taylor B.P., etal. (2012). A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders. The American Journal of Psychiatry, 169, 292-299.
28. Hughes, C., Russell, J., & Robbins T.W. (1994). Evidence for executive dysfunction in autism. Neuropsychologia, 32, 477-492.
29. Kaland, N., Mortensen, E.L., & Smith, L. (2007). Disembedding performance in children and adolescents with Asperger syndrome or high-functioning autism. Autism: The International Journal of Research and Practice, 11, 81-92.
30. Kim, J., & Ragozzino, M.E. (2005). The involvement of the orbitofrontal cortex in learning under changing task contingencies. Neurobiology of Learning and Memory, 83, 125-133.
31. Lam, K.S., & Aman, M.G. (2007). The repetitive behavior scale-revised: Independent validation in individuals with autism spectrum disorders. Journal of Autism and Developmental Disorders, 37, 855-866.
32. Lindgren, H.S., Wickens, R., Tait, D.S., Brown, V.J., & Dunnett, S.B. (2013). Lesions of the dorsomedial striatum impair formation of attentional set in rats. Neuropharmacology, 71, 148-153.
33. Marek, G.J., Martin-Ruiz, R., Abo, A., & Artigas, F. (2005). The selective 5-HT2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine. Neuropsychopharmacology, 30, 2205-2215.
34. McCool, M.F., Patel, S., Talati, R., & Ragozzino, M.E. (2008). Differential involvement of M1-type and M4-type muscarinic cholinergic receptors in the dorsomedial striatum in task switching. Neurobiology of Learning and Memory, 89, 114-124.
35. McCracken, J.T., McGough, J., Shah, B., Cronin, P., Hong, D., etal. (2002). Risperidone in children with autism and serious behavioral problems. New England Journal of Medicine, 347, 314-321.
36. McDougle, C.J., Kresch, L.E., & Posey, D.J. (2000). Repetitive thoughts and behavior in pervasive developmental disorders: Treatment with serotonin reuptake inhibitors. Journal of Autism and Developmental Disorders, 30, 427-435.
37. McDougle, C.J., Scahill, L., Aman, M.G., McCracken, J.T., Tierney, E., etal. (2005). Risperidone for the core symptom domains of autism: Results from the study by the autism network of the research units on pediatric psychopharmacology. The American Journal of Psychiatry, 162, 1142-1148.
38. McFarlane, H.G., Kusek, G.K., Yang, M., Phoenix, J.L., Bolivar, V.J., & Crawley, J.N. (2008). Autism-like behavioral phenotypes in BTBR T+tf/J mice. Genes, Brain, and Behavior, 7, 152-163.
39. McPheeters, M.L., Warren, Z., Sathe, N., Bruzek, J.L., Krishnaswami, S., etal. (2011). A systematic review of medical treatments for children with autism spectrum disorders. Pediatrics, 127, 1312-1321.
40. 2 receptor antagonist sulpiride in human volunteers. Psychopharmacology, 176, 331-342.
41. Mehta, M.A., Sahakian, B.J., McKenna, P.J., & Robbins, T.W. (1999). Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson's disease. Psychopharmacology, 146, 162-174.
42. Memari, A.H., Ziaee, V., Shayestehfar, M., Ghanouni, P., Mansournia, M.A., & Moshayedi, P. (2013). Cognitive flexibility impairments in children with autism spectrum disorders: Links to age, gender and child outcomes. Research in Developmental Disabilities, 34, 3218-3225.
43. Moy, S.S., Nadler, J.J., Young, N.B., Nonneman, N.J., Segall, S.K., & Andrade, G.M. (2008). Social approach and repetitive behavior in eleven inbred mouse strains. Behavioural Brain Research, 191, 118-129.
44. Mulder, E.J., Anderson, G.M., Kema, I.P., de Bildt, A., van Lang, N.D., etal. (2004). Platelet serotonin levels in pervasive developmental disorders and mental retardation: Diagnostic group differences, within-group distribution, and behavioral correlates. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 491-499.
45. Owley, T., Walton, L., Salt, J., Guter, S.J. Jr., Winnega, M., etal. (2005). An open-label trial of escitalopram in pervasive developmental disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 44, 343-348.
46. Ozonoff, S., & Jensen, J. (1999). Brief report: Specific executive function profiles in three neurodevelopmental disorders. Journal of Autism and Developmental Disorders, 29, 171-177.
47. Ozonoff, S., Pennington, B.F., & Rogers, S.J. (1991). Executive function deficits in high-functioning autistic individuals: Relationship to theory of mind. Journal of Child Psychology and Psychiatry, 32, 1081-1105.
48. Palencia, C.A., & Ragozzino, M.E. (2006). The effect of N-methyl-d-aspartate receptor blockade on acetylcholine efflux in the dorsomedial striatum during response reversal learning. Neuroscience, 143, 671-678.
49. Pearson, B.L., Pobbe, R.L., Defensor, E.B., Oasay, L., Bolivar, V.J., etal. (2011). Motor and cognitive stereotypies in the BTBR T+tf/J mouse model of autism. Genes, Brain, and Behavior, 216, 228-235.
50. Peñagarikano, O., Abrahams, B.S., Herman, E.I., Winden, K.D., Gdalyahu, A., etal. (2011). Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell, 147, 235-246.
51. Pobbe, R.L., Pearson, B.L., Defensor, E.B., Bolivar, V.J., Blanchard, D.C., & Blanchard, R.J. (2010). Expression of social behaviors of C57BL/6J versus BTBR inbred mouse strains in the visible burrow system. Behavioural Brain Research, 214, 443-449.
52. Politte, L.C., & McDougle, C.J. (2014). Atypical antipsychotics in the treatment of children and adolescents with pervasive developmental disorders. Psychopharmacology, 231, 1023-1036.
53. Pooragha, F., Kafi, S.M., & Sotodeh, S.O. (2013). Comparing response inhibition and flexibility for two components of executive functioning in children with autism spectrum disorder and normal children. Iranian Journal of Pediatrics, 23, 309-314.
54. Quesseveur, G., Repérant, C., David, D.J., Gardier, A.M., Sanchez, C., & Guiard, B.P. (2013). 5-HT2A receptor inactivation potentiates the acute antidepressant-like activity of escitalopram: Involvement of the noradrenergic system. Experimental Brain Research, 226, 285-295.
55. Ragozzino, M.E., & Choi, D. (2004). Dynamic changes in acetylcholine output in the medial striatum during place reversal learning. Learning & Memory, 11, 70-77.
56. Ragozzino, M.E., Ragozzino, K.E., Mizumori, S.J., & Kesner, R.P. (2002). Role of the dorsomedial striatum in behavioral flexibility for response and visual cue discrimination learning. Behavioral Neuroscience, 116, 105-115.
57. Rapin, I., & Tuchman, R.F. (2008). Autism: Definition, neurobiology, screening, diagnosis. Pediatric Clinics of North America, 55, 1129-1146.
58. Robinson, S., Goddard, L., Dritschel, B., Wisley, M., & Howlin, P. (2009). Executive functions in children with autism spectrum disorders. Brain and Cognition, 71, 362-368.
59. Rosenbaum, J.F.A.G., Hyman S.E., Labbate L.A., & Fava M. (2005). Handbook of psychiatric drug therapy (5th ed.). Philadelphia, PA: Lippincott Williams & Wilkins.
60. Rummel-Kluge, C., Komossa, K., Schwarz, S., Hunger, H., Schmid, F., etal. (2010). Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis. Schizophrenia Research, 123, 225-233.
61. Schotte, A., Janssen, P.F.M., Gommeren, W.H.M.L., Luyten, W.H.M.L., Van Gompel, P., etal. (1996). Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding. Psychopharmacology, 124, 57-73.
62. Scott, L.J., & Dhillon, S. (2007). Risperidone. Pediatric Drugs, 9, 343-354.
63. Silverman, J.L., Tolu, S.S., Barkan, C.L., & Crawley, J.N. (2010). Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP. Neuropsychopharmacology, 35, 976-989.
64. Solomon, M., Smith, A.C., Frank, M.J., Ly, S., & Carter, C.S. (2011). Probabilistic reinforcement learning in adults with autism spectrum disorders. Autism Research, 4, 109-120.
65. Sutcliffe, J.S., Delahanty, R.J., Prasad, H.C., McCauley, J.L., Han, Q., etal. (2005). Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. The American Journal of Human Genetics, 77, 265-279.
66. Szatmari, P., Georgiades, S., Bryson, S., Zwaigenbaum, L., Roberts, W., etal. (2006). Investigating the structure of the restricted, repetitive behaviours and interests domain of autism. Journal of Child Psychology and Psychiatry, 47, 582-590.
67. Tait, D.S., & Brown, V.J. (2008). Lesions of the basal forebrain impair reversal learning but not shifting of attentional set in rats. Behavioural Brain Research, 187, 100-108.
68. Tait, D.S., Brown, V.J., Farovik, A., Theobald, D.E., Dalley, J.W., & Robbins, T.W. (2007). Lesions of the dorsal noradrenergic bundle impair attentional set-shifting in the rat. The European Journal of Neuroscience, 25, 3719-3724.
69. 2A receptor occupancy in M100907-treated schizophrenic patients. Psychopharmacology, 148, 400-403.
70. Tandon, R. (2002). Safety and tolerability: How do newer generation "atypical" antipsychotics compare? The Psychiatric Quarterly, 73, 297-311.
71. Thomas, A., Burant, A., Bui, N., Graham, D., Yuva-Paylor, L.A., & Paylor, R. (2009). Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety. Psychopharmacology, 204, 361-373.
72. Turner, M. (1999). Annotation: Repetitive behaviour in autism: A review of psychological research. Journal of Child Psychology and Psychiatry, 40, 839-849.
73. Van Golf Racht-Delatour, B., & El Massioui, N. (1999). Rule-based learning impairment in rats with lesions to the dorsal striatum. Neurobiology of Learning and Memory, 72, 47-61.
74. Veenstra-VanderWeele, J., Kim, S.J., Lord, C., Courchesne, R., Akshoomoff, N., etal. (2002). Transmission disequilibrium studies of the serotonin 5-HT2A receptor gene (HTR2A) in autism. American Journal of Medical Genetics, 114, 277-283.
75. Veenstra-VanderWeele, J., Muller, C.L., Iwamoto, H., Sauer, J.E., Owens, W.A., etal. (2012). Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proceedings of the National Academy of Sciences of the United States of America, 109, 5469-5474.
76. Vollenweider, F.X., Vollenweider-Scherpenhuyzen, M.F., Bäbler, A., Vogel, H., & Hell, D. (1998). Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport, 9, 3897-3902.
77. Williams, D., & Jarrold, C. (2013). Assessing planning and set-shifting abilities in Autism: Are experimenter-administered and computerised versions of tasks equivalent? Autism Research, 6, 461-467.
78. Yang, M., Scattoni, M.L., Zhodzishsky, V., Chen, T., Caldwell, H., etal. (2007). Social approach behaviors are similar on conventional versus reverse lighting cycles, and in replications across cohorts, in BTBR T+tf/J, C57BL/6J, and vasopressin receptor 1B mutant mice. Frontiers in Behavioral Neuroscience, 2, 1. doi:10.3389/neuro.08.001.2007.